Formulation & IngredientsExplainerSupplement Brand FoundersFormulation & R&D Teams

The Gummy Gamble: Manufacturing NAD+ Precursors

Gummies are the darlings of the supplement world. Consumers love them. Retailers love them. But making a NAD+ precursor gummy that actually delivers what the label promises? That's where the romance ends and the hard science begins.

Most brands jump into gummies because they're popular. They don't understand that nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), the two most common NAD+ precursors, are among the most difficult ingredients to formulate into a stable, palatable, shelf-stable gummy. Heat degrades them. Acidity destroys them. And their bitterness can make even the best fruit flavors taste like regret.

At KorNutra, we've spent years figuring out how to do it right. Here's what most manufacturers won't tell you, and why you should care.

Heat: The Silent Potency Killer

Standard gummy manufacturing runs hot. Really hot. Gelatin or pectin needs temperatures between 80°C and 95°C to dissolve and set properly. That works fine for vitamin C or zinc. It's a disaster for NAD+ precursors.

We ran our own stability tests. After just 24 hours at typical gummy processing temperatures, NMN can lose 30-40% of its potency. That 250 mg per gummy on your label? You could be delivering 150 mg, or less, by the time it reaches the consumer. The molecule hydrolyzes into plain nicotinamide, a different compound than the NMN on your label.

The fix? You can't just turn down the heat. You have to change the process entirely.

At KorNutra, we use a low-temperature incorporation method. The active ingredient is added only after the base gummy mass has cooled below 50°C. This requires careful timing, specialized mixing equipment, and real-time temperature monitoring at every step. It's slower. It's more expensive. But it preserves the molecule.

The pH Tightrope

Gummies need acid to set. Citric acid and malic acid lower the pH to around 3.0-4.0, which helps the gummy firm up and gives it that tart, candy-like taste.

Unfortunately, most NAD+ precursors start hydrolyzing (breaking down in the presence of water) when the pH drops below 4.5. The more acidic the gummy, the faster the active ingredient disappears.

Our solution was developing a buffered gummy matrix. Using a carefully balanced blend of sodium citrate and potassium phosphate, we keep the internal pH high enough to protect the precursor while maintaining the external tartness consumers expect. It took dozens of trials to get the ratio right. One wrong adjustment, and the gummy turns into a sticky mess that loses potency within weeks.

The Taste Masking Triple Threat

Let's be honest: NAD+ precursors taste terrible. They're intensely bitter, with a metallic, lingering aftertaste that standard sweeteners can't hide. Most manufacturers try drowning it in high-intensity sweeteners or strong fruit flavors. It doesn't work. Consumers chew the gummy, swallow, and then the bitterness creeps back.

We use a multi-layer approach:

  • Encapsulation: Each particle of the active ingredient is coated in a lipid-based shell. This prevents direct contact with taste receptors during chewing.
  • Flavor synergy: Single fruit flavors can't mask the bitterness. We blend citrus (to offset metallic notes) with a hint of natural vanilla (to smooth out the finish).
  • Texture modulation: A softer gummy matrix releases the active gradually, rather than dumping it all at once.

Even with these techniques, achieving a taste score above 7 out of 10 in blind panels requires iterative reformulation. It's not something you can copy from a competitor or shortcut with extra stevia.

Uniformity: The Hidden Liability

Gummy manufacturing means pouring a hot, viscous liquid into starch molds. If your active ingredient isn't evenly dispersed before pouring, some gummies get 300 mg, others get 100 mg. That is a quality issue and a regulatory liability.

NAD+ precursors are dense powders that settle quickly in suspension. We combat this with a continuous high-shear mixing system that keeps the dispersion uniform from the first gummy to the last. Every ten minutes during production, we pull a sample and run it through HPLC to verify potency. If the variation exceeds 5%, the entire batch is quarantined.

The Regulatory Reality

The regulatory ground has shifted, and the two precursors now sit in different positions. Nicotinamide riboside chloride, the stable salt form of NR sold to supplement makers, has an acknowledged NDI notification and an FDA no-questions GRAS response covering gum and chews. NMN has had a rougher path. In November 2022 the FDA concluded NMN was excluded from the dietary supplement definition under the drug preclusion clause. After a citizen petition and litigation from the Natural Products Association, the agency reversed itself. On September 29, 2025, it concluded NMN is not excluded and may be lawfully marketed as a dietary supplement, and in December 2025 it reinstated NDI notifications for NMN.

That is not a free pass for a gummy launch. NDI notifications are ingredient-specific and tied to conditions of use, and a gummy is not the same condition of use as a capsule or powder. Before you put NMN in a gummy, confirm that your supplier's notification covers your formulation and serving size, or plan to file your own. We cannot and do not formulate for any health benefits: no "anti-aging," no "cellular repair," no implied medical claims. Our job is manufacturing excellence: stability, potency, purity, and taste. That's it.

Every batch we produce follows strict cGMP protocols:

  1. Raw materials tested with certificates of analysis for every lot
  2. In-process checks for degradation byproducts like nicotinamide
  3. Final product testing for label claim, heavy metals, and microbials
  4. Accelerated stability studies at 40°C and 75% relative humidity to project real-world shelf life

What the Ingredient Costs

Stability failures hit the margin as hard as the lab, because the active is the most expensive thing in the gummy. High-purity NMN powder (99% or better) currently runs roughly $400 to $1,200 per kilogram depending on supplier, production method, and order size. At 250 mg per gummy, the active alone costs $0.10 to $0.30 per piece before you add the base, encapsulation, packaging, and labor.

Overage makes it worse. To guarantee 250 mg at the end of shelf life, you have to put in more than 250 mg at the start, and the overage follows the degradation curve. A 10% overage on a 500,000-piece run at $1,000 per kilogram is an extra $12,500 of raw material you will never sell as label claim. That number grows with every point of potency lost in processing.

NR chloride is a different cost story. It is a patented ingredient (Niagen, from Niagen Bioscience), and at least one distributor has paused sales citing patent considerations. Budget for a premium there, and confirm your supplier's status before you build a launch plan around it.

This is why process choices are pricing choices. A manufacturer that loses 30% of potency in the cook ships a weak product and burns your most expensive input, and someone has to pay for the replacement. Low-temperature incorporation and buffering cost more upfront and waste less downstream.

Why This Matters to You

If you're considering an NAD+ precursor gummy, don't assume all manufacturers are equal. Ask the hard questions:

  • What is the degradation curve for your specific active at your manufacturing temperature?
  • Can you show HPLC data proving potency retention over 24 months?
  • What are your taste panel scores for bitterness, not just sweetness?

If they can't answer, they're gambling with your brand's reputation.

At KorNutra, we've already run these trials. We've invested in the equipment and the expertise because we believe that in nutraceuticals, the manufacturing process is the product. Get that right, and everything else follows.

The gummy gamble doesn't have to be a gamble. Choose a partner who understands the science.

← Back to Blog